SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PSDV - pSivida Limited
PSDV 1.220+14.0%Mar 29 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Arthur Radley who wrote (346)12/24/2010 2:19:05 PM
From: John McCarthy   of 421
 
Hi Arthur

Sorry about the erase - nuff said.

Being stupid (me) has its advantages - and therefore -
I'is hanging out till the end of this.

ALIM is taking the FDA-adopted International Conference on Harmonization guidance route here which

(a) does not oblige the FDA to follow - but -

(b) gets the Intent To Treat *doctrine* on the table
and in play. ALIM's actions prove this - imo.

I did not fully understand *how* ALIM got on Priority
and now I do - the 24 month data was significantly better
than the 18 month stuff - and thats all it took - in terms
of color by number procedures.

If we are just dead catfish - in sewar water - why prolong
the agony and just give ALIM a non-approval letter and be
done with it versus dragging this out another 6 to 9 months?

Maybe thats the way its done - I'm out of touch - but
I hope not.

If the price of gold blows up this winter its gonna
be a frigid winter -g-

Happy Holidays to you and your family.

regards
John
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext